Weight Loss Prior Mamma Reduction - A Pilot Study (MAMMARED)
Primary Purpose
Weight Loss, Hypertrophy
Status
Completed
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Low energy diet
Sponsored by
About this trial
This is an interventional treatment trial for Weight Loss
Eligibility Criteria
Inclusion Criteria:
- entitled to mammoplasty,
- motivated towards participation in a weight loss program
- BMI within the range 25.5 to 35 kg/m2
Exclusion Criteria:
- more than 65 years of age
- insulin-dependent diabetes
- chronic heart, liver or kidney failure
Sites / Locations
- Copenhagen University Hospital at Herlev (EFFECT)
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Low energy diet
Arm Description
Low energy diet (800 kcal/d) for eight weeks, following 4 weeks on reintroduction supplying 1200 kcal/d.
Outcomes
Primary Outcome Measures
Weight loss
Measurement of weight to nearest 0.1 kg on category III approved body weight
Secondary Outcome Measures
Breast volumen
measure of breast volumen
Breast size
anthropometric measurements of the breasts by measuring tape.
Pain and discomfort
Questionnaire on pain in head, neck, shoulders
Full Information
NCT ID
NCT02659371
First Posted
November 9, 2015
Last Updated
August 3, 2016
Sponsor
Copenhagen University Hospital at Herlev
1. Study Identification
Unique Protocol Identification Number
NCT02659371
Brief Title
Weight Loss Prior Mamma Reduction - A Pilot Study
Acronym
MAMMARED
Official Title
Weight Loss by Low Energy Diet as Treatment Prior Mamma Reduction in Overweight Women - A Pilot Study
Study Type
Interventional
2. Study Status
Record Verification Date
August 2016
Overall Recruitment Status
Completed
Study Start Date
January 2015 (undefined)
Primary Completion Date
January 2015 (Actual)
Study Completion Date
May 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Copenhagen University Hospital at Herlev
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Due to a higher risk of complications, obese and overweight patients with macromastia are in Denmark prohibited mammoplasty , as BMI must be within normal range, i.e. BMI < 25 kg/m2.
The study is a pilot study with a diet intervention group and no control group. The intervention is a 12 week low energy diet pre-operative weight loss program investigating if this will result in weight loss making the overweight and obese patients eligible for breast reduction surgery i.e. BMI < 25.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Weight Loss, Hypertrophy
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
6 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Low energy diet
Arm Type
Experimental
Arm Description
Low energy diet (800 kcal/d) for eight weeks, following 4 weeks on reintroduction supplying 1200 kcal/d.
Intervention Type
Dietary Supplement
Intervention Name(s)
Low energy diet
Primary Outcome Measure Information:
Title
Weight loss
Description
Measurement of weight to nearest 0.1 kg on category III approved body weight
Time Frame
12 weeks
Secondary Outcome Measure Information:
Title
Breast volumen
Description
measure of breast volumen
Time Frame
12 weeks
Title
Breast size
Description
anthropometric measurements of the breasts by measuring tape.
Time Frame
12 weeks
Title
Pain and discomfort
Description
Questionnaire on pain in head, neck, shoulders
Time Frame
12 weeks
Other Pre-specified Outcome Measures:
Title
Blood bio markers
Description
Blood sampling and analyses of blood bio markers, e.g. lipids
Time Frame
12 weeks
Title
Hip circumference
Description
Measurements of hip circumference to nearest 0.1 cm by measuring tape, repeated three times.
Time Frame
12 weeks
Title
Waist circumference
Description
Measurements of waist circumference to nearest 0.1 cm by measuring tape, repeated three times.
Time Frame
12 weeks
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
entitled to mammoplasty,
motivated towards participation in a weight loss program
BMI within the range 25.5 to 35 kg/m2
Exclusion Criteria:
more than 65 years of age
insulin-dependent diabetes
chronic heart, liver or kidney failure
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Arne Astrup, MDDrMedSci
Organizational Affiliation
University of Copenhagen
Official's Role
Principal Investigator
Facility Information:
Facility Name
Copenhagen University Hospital at Herlev (EFFECT)
City
Herlev
ZIP/Postal Code
2730
Country
Denmark
12. IPD Sharing Statement
Learn more about this trial
Weight Loss Prior Mamma Reduction - A Pilot Study
We'll reach out to this number within 24 hrs